Table 2.
HF‐NCAD | HF‐CAD | SVD | MVD | LM | P value a | |
---|---|---|---|---|---|---|
n = 13 838 | n = 8619 | n = 3252 | n = 2052 | n = 3315 | ||
Age, year [mean (SD)] | 61 (11) | 67 (10) | 66 (9) | 67 (9) | 68 (9) | <0.001 |
Age category (%) | <0.001 | |||||
<59 years | 41.2 | 19.4 | 22.2 | 19.8 | 16.4 | |
60–69 years | 32.9 | 34.5 | 34.7 | 34.6 | 34.2 | |
70–79 years | 22.3 | 37.0 | 35.3 | 37.3 | 38.5 | |
≥80 years | 3.6 | 9.1 | 7.8 | 8.2 | 10.9 | |
Male sex (%) | 68.9 | 80.4. | 77.0 | 81.4 | 83.2 | <0.001 |
Diabetes (%) | 14.8 | 32.0 | 25.2 | 33.3 | 38 | <0001 |
BMI, kg/m2 (SD) | 28.1 (5.9) | 27.8 (6.9) | 27.9 (8.2) | 27.9 (6.8) | 27.6 (5.2) | 0.005 |
Hypertension (%) | 50.1 | 64.9 | 61.5 | 65.5 | 67.9 | <0.001 |
Missing | 1.0 | 1.4 | 1.4 | 1.3 | 1.4 | |
Previous MI (%) | 0 | 35.3 | 26.4 | 37.7 | 42.7 | <0.001 |
Missing | 1.9 | 3.8 | 3.8 | 3.6 | 3.6 | |
Previous PCI | 1.6 | 16.9 | 16.4 | 19.9 | 15.4 | <0001 |
Previous CABG | 0.6 | 14.7 | 4.0 | 10.7 | 27.6 | <0001 |
eGFR (mL/min/1.73 m2) | <0001 | |||||
≥60 mL/min (%) | 87.5 | 76.3 | 79.6 | 76.5 | 72.8 | |
<60 mL/min (%) | 12.5 | 23.7 | 20.4 | 23.5 | 27.2 | |
Smoking (%) | ||||||
Never smoker | 44.6 | 33.0 | 34.1 | 31.9 | 32.5 | |
Past smoker | 36.6 | 43.5 | 42.7 | 43.3 | 44.6 | <0.001 |
Current smoker | 14.4 | 18.0 | 18.2 | 19.0 | 17.2 | |
Missing | 4.4 | 5.4 | 5.0 | 5.8 | 5.7 | |
Smokeless tobacco (%) | <0.001 | |||||
Never user | 71.9 | 70.4 | 71.8 | 70.4 | 69.0 | |
Past user | 5.7 | 6.0 | 6.1 | 5.5 | 6.1 | |
Current user | 9.7 | 7.5 | 8.4 | 7.2 | 6.7 | |
Missing | 12.7 | 16.2 | 13.7 | 16.9 | 18.2 | |
ASA (%) | 15.7 | 64.2 | 65.6 | 67.2 | 59.5 | <0001 |
Statins (%) | 29.7 | 58.7 | 51.7 | 60.8 | 64.3 | <0001 |
Missing | 1.4 | 1.7 | 1.5 | 1.6 | 2.0 | |
Amount of contrast [mL (SD)] | 62 (31) | 108 (70) | 101 (62) | 120 (80) | 106 (66) | <0.001 |
Radiation time [s (SD)] | 242 (232) | 570 (671) | 518 (658) | 673 (773) | 557 (607) | <0.001 |
ASA, acetylsalicylic acid; CABG, coronary artery bypass grafting; eGFR, estimated glomerular filtration rate (Cockcroft–Gault); HF‐CAD, heart failure with coronary artery disease (i.e. SVD + MVD + LM); HF‐NCAD, heart failure with normal/non‐obstructive coronary artery disease; LM, stenosis > 50% in left main coronary artery; MI, myocardial infarction, MVD, multivessel disease (stenosis > 50% in more than one coronary artery without left main disease); Normal/non‐obstructive, no stenosis > 50% in coronary arteries; PCI, percutaneous coronary intervention; SVD, single‐vessel diseases (stenosis > 50% in one coronary artery).
Compared with HF‐NCAD.